Hemp vs OrganiGram Which Is More Attractive?

Hemp and OrganiGram stocks are two popular investment options in the ever-growing cannabis industry. While both offer potential for significant returns, they represent different segments of the market. Hemp stocks are typically focused on the production and distribution of hemp-derived products, such as CBD oil, while OrganiGram stocks are centered around the cultivation and sale of medical and recreational cannabis. Understanding the distinctions between these two sectors can help investors make informed decisions about where to allocate their funds for maximum profit potential.

Hemp or OrganiGram?

When comparing Hemp and OrganiGram, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Hemp and OrganiGram.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Hemp has a dividend yield of -%, while OrganiGram has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Hemp reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, OrganiGram reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Hemp P/E ratio at 0.00 and OrganiGram's P/E ratio at -2.99. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Hemp P/B ratio is 0.00 while OrganiGram's P/B ratio is 0.74.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Hemp has seen a 5-year revenue growth of 0.00%, while OrganiGram's is 3.45%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Hemp's ROE at 0.00% and OrganiGram's ROE at -26.61%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $0.00 for Hemp and $1.45 for OrganiGram. Over the past year, Hemp's prices ranged from $0.00 to $0.00, with a yearly change of 1900.00%. OrganiGram's prices fluctuated between $1.21 and $2.91, with a yearly change of 140.10%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.